Similar Search Results

Global health in practice : investing amidst pandemics, denial of evidence, and neo-dependency

Adeyi, Olusoji - 2022

"The COVID-19 pandemic has laid bare the world's vulnerabilities to health and economic ruin from disease outbreaks. But the pandemic merely reveals fundamental weaknesses and contradictions in global health. What are the roots of discontents in global health? How do geo-politics, power...

Persistent link: https://www.econbiz.de/10012628740

Innovation in the biopharmaceutical industry

Atun, Rifat A. (ed.); Sheridan, Desmond John (contributor) - 2007

Persistent link: https://www.econbiz.de/10003414600

1998 - 2001 in the pharma industry : from deep river to white water rapids

Bosanquet, Nick; Atun, Rifat - In: The European business journal 13 (2001) 2, pp. 74-82

Persistent link: https://www.econbiz.de/10001609215

National drug stockout risks and the global fund disbursement process for procurement

Gallien, Jérémie; Rashkova, Iva; Atun, Rifat A.; … - In: Production and operations management : an international … 26 (2017) 6, pp. 997-1014

Persistent link: https://www.econbiz.de/10011718147

The global economic burden of diabetes in adults aged 20-79 years: a cost-of-illness study

Bommer, Christian; Heesemann, Esther Luise; Sagalova, Vera - In: Essays on health and development, (pp. 25-38). 2018

Persistent link: https://www.econbiz.de/10011913351

Global economic burden of diabetes in adults: projections from 2015-2030

Bommer, Christian; Heesemann, Esther Luise; Sagalova, Vera - In: Essays on health and development, (pp. 39-53). 2018

Persistent link: https://www.econbiz.de/10011913353

Innovation in the Biopharmaceutical Industry.

Atun, Rifat A. - 2014

Key Features:A great team of contributors who are specialists from all the critical branches or fields in biopharmacy, such as BioPharma Business Development; Centre for Health Management; Bioengineering; School of Medicine; and Intellectual Property Institute.

Persistent link: https://www.econbiz.de/10012684505